Large-scale testing (Phase 3)Study completedNCT03930641
What this trial is testing
Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration
Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 34